BGI Genomics Co (300676.SZ) Stock Price

BGI Genomics Co Price

SZSE·CLOSED
40.00CNY+1.01 (+2.56 %)
Market closed

Over the last 10 years BGI Genomics Co grew revenue by 13.1% annually, reaching 3.87 B CNY. Earnings per share have grown at 7.8% per year over the last 9 years. For BGI Genomics Co, the net margin of -23.3% is down versus 24.9% a few years ago. At today's price the dividend yield works out to roughly 0.25%. The consensus 12-month price target for BGI Genomics Co is 58.87 CNY, about 47.2% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 23% above its 52-week low.

BGI Genomics Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of BGI Genomics Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how BGI Genomics Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing BGI Genomics Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

BGI Genomics Co Stock Price History
DateBGI Genomics Co Price
8/5/202640.00 CNY
8/4/202638.99 CNY
8/3/202638.00 CNY
7/31/202638.49 CNY
7/30/202636.89 CNY
7/29/202637.13 CNY
7/28/202637.00 CNY
7/27/202637.64 CNY
7/24/202636.50 CNY
7/23/202636.61 CNY
7/22/202637.49 CNY
7/21/202636.75 CNY
7/20/202636.26 CNY
7/17/202636.11 CNY
7/16/202638.03 CNY
7/15/202637.37 CNY
7/14/202636.11 CNY
7/13/202636.13 CNY
7/10/202636.21 CNY
7/9/202634.75 CNY
7/8/202634.30 CNY
7/7/202634.63 CNY
7/6/202636.18 CNY
7/3/202636.95 CNY
7/2/202635.86 CNY
7/1/202636.85 CNY
6/30/202635.06 CNY
6/29/202635.90 CNY
6/26/202634.66 CNY
6/25/202636.31 CNY
6/24/202635.62 CNY
6/23/202636.00 CNY
6/22/202634.95 CNY
6/18/202635.62 CNY
6/17/202634.17 CNY
6/16/202634.13 CNY
6/15/202634.02 CNY
6/12/202633.91 CNY
6/11/202632.64 CNY
6/10/202633.74 CNY
6/9/202634.12 CNY
6/8/202633.60 CNY
6/5/202635.36 CNY
6/4/202634.80 CNY
6/3/202635.41 CNY
6/2/202636.10 CNY
6/1/202636.36 CNY
5/29/202636.59 CNY
5/28/202636.40 CNY
5/27/202636.85 CNY
5/26/202637.47 CNY
5/25/202638.41 CNY
5/22/202637.49 CNY
5/21/202639.80 CNY
5/20/202639.56 CNY
5/19/202640.32 CNY
5/18/202640.00 CNY
5/15/202640.75 CNY
5/14/202640.85 CNY
5/13/202642.18 CNY
5/12/202642.59 CNY
5/11/202644.90 CNY
5/8/202643.08 CNY
5/7/202641.28 CNY
5/6/202640.45 CNY
4/30/202639.94 CNY
4/29/202640.30 CNY
4/28/202640.28 CNY
4/27/202641.22 CNY
4/24/202638.81 CNY
4/23/202639.09 CNY
4/22/202639.77 CNY
4/21/202639.73 CNY
4/20/202640.36 CNY
4/17/202639.87 CNY
4/16/202640.36 CNY
4/15/202640.23 CNY
4/14/202640.38 CNY
4/13/202639.84 CNY
4/10/202640.25 CNY
4/9/202639.81 CNY
4/8/202641.21 CNY
4/7/202639.25 CNY
4/3/202639.11 CNY
4/2/202640.55 CNY
4/1/202641.12 CNY
3/31/202639.85 CNY
3/30/202640.29 CNY
3/27/202640.03 CNY
3/26/202639.02 CNY
3/25/202639.98 CNY
3/24/202639.35 CNY
3/23/202638.41 CNY
3/20/202642.15 CNY
3/19/202643.45 CNY
3/18/202644.67 CNY
3/17/202644.21 CNY
3/16/202644.62 CNY
3/13/202644.21 CNY
3/12/202644.64 CNY
3/11/202644.89 CNY
3/10/202645.24 CNY
3/9/202644.53 CNY
3/6/202645.09 CNY
3/5/202644.42 CNY
3/4/202643.90 CNY
3/3/202644.78 CNY
3/2/202646.98 CNY
2/27/202648.59 CNY
2/26/202648.10 CNY
2/25/202649.22 CNY
2/24/202648.64 CNY
2/13/202649.07 CNY
2/12/202649.35 CNY
2/11/202649.65 CNY
2/10/202649.84 CNY
2/9/202649.59 CNY
2/6/202649.00 CNY
2/5/202649.60 CNY
2/4/202650.36 CNY
2/3/202650.30 CNY
2/2/202649.04 CNY
1/30/202650.58 CNY
1/29/202652.09 CNY
1/28/202650.74 CNY
1/27/202653.05 CNY
1/26/202653.44 CNY
1/23/202653.71 CNY
1/22/202652.27 CNY
1/21/202651.94 CNY
1/20/202651.01 CNY
1/19/202651.23 CNY
1/16/202653.00 CNY
1/15/202656.90 CNY
1/14/202659.25 CNY
1/13/202658.01 CNY
1/12/202654.70 CNY
1/9/202651.69 CNY
1/8/202648.04 CNY
1/7/202647.47 CNY
1/6/202647.89 CNY
1/5/202647.44 CNY
12/31/202545.36 CNY
12/30/202545.38 CNY
12/29/202545.88 CNY
12/26/202545.88 CNY
12/25/202545.79 CNY
12/24/202545.36 CNY
12/23/202545.02 CNY
12/22/202545.56 CNY
12/19/202545.90 CNY
12/18/202546.04 CNY
12/17/202545.68 CNY
12/16/202544.90 CNY
12/15/202545.02 CNY
12/12/202545.71 CNY
12/11/202544.01 CNY
12/10/202544.86 CNY
12/9/202544.64 CNY
12/8/202545.00 CNY
12/5/202545.03 CNY
12/4/202544.66 CNY
12/3/202544.65 CNY
12/2/202545.74 CNY
12/1/202546.72 CNY
11/28/202546.65 CNY
11/27/202546.37 CNY
11/26/202546.55 CNY
11/25/202546.70 CNY
11/24/202546.51 CNY
11/21/202545.90 CNY
11/20/202547.29 CNY
11/19/202547.81 CNY
11/18/202548.55 CNY
11/17/202548.40 CNY
11/14/202549.07 CNY
11/13/202549.18 CNY
11/12/202549.50 CNY
11/11/202548.71 CNY
11/10/202549.05 CNY
11/7/202547.71 CNY
11/6/202548.08 CNY
11/5/202548.85 CNY
11/4/202548.60 CNY
11/3/202549.19 CNY
10/31/202549.20 CNY
10/30/202548.60 CNY
10/29/202548.33 CNY
10/28/202548.15 CNY
10/27/202548.33 CNY
10/24/202547.82 CNY
10/23/202547.66 CNY
10/22/202547.50 CNY
10/21/202547.77 CNY
10/20/202546.55 CNY
10/17/202546.57 CNY
10/16/202547.89 CNY
10/15/202548.55 CNY
10/14/202548.18 CNY
10/13/202548.70 CNY
10/10/202549.67 CNY
10/9/202550.15 CNY
9/30/202549.16 CNY
9/29/202548.39 CNY
9/26/202548.75 CNY
9/25/202549.58 CNY
9/24/202549.68 CNY
9/23/202548.92 CNY
9/22/202550.41 CNY
9/19/202550.69 CNY
9/18/202551.05 CNY
9/17/202551.79 CNY
9/16/202552.45 CNY
9/15/202553.20 CNY
9/12/202554.91 CNY
9/11/202551.88 CNY
9/10/202550.95 CNY
9/9/202552.08 CNY
9/8/202553.16 CNY
9/5/202551.06 CNY
9/4/202549.98 CNY
9/3/202550.98 CNY
9/2/202551.96 CNY
9/1/202553.92 CNY
8/29/202553.80 CNY
8/28/202554.45 CNY
8/27/202554.60 CNY
8/26/202554.55 CNY
8/25/202555.12 CNY
8/22/202553.45 CNY
8/21/202551.76 CNY
8/20/202551.56 CNY
8/19/202551.80 CNY
8/18/202552.39 CNY
8/15/202551.60 CNY
8/14/202550.52 CNY
8/13/202552.25 CNY
8/12/202552.24 CNY
8/11/202552.93 CNY
8/8/202552.18 CNY
Access this data via the Eulerpool API
Get Free API Key

BGI Genomics Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
6.77 B CNY
1.67 B CNY
1.46 B CNY
Jan 1, 2022
7.05 B CNY
809.58 M CNY
802.92 M CNY
Jan 1, 2023
4.35 B CNY
126.93 M CNY
92.90 M CNY
Jan 1, 2024
3.87 B CNY
-644.65 M CNY
-902.69 M CNY
Jan 1, 2025 (e)
3.60 B CNY
43.51 M CNY
24.74 M CNY
Jan 1, 2026 (e)
3.89 B CNY
46.90 M CNY
70.10 M CNY
Jan 1, 2027 (e)
4.13 B CNY
49.86 M CNY
65.98 M CNY
Jan 1, 2028 (e)
4.48 B CNY
54.03 M CNY
136.08 M CNY

BGI Genomics Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 4:06 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITB CNY
EBIT MARGIN%
NET INCOMEB CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e2026e2027e2028e
1.131.321.712.102.542.808.406.777.054.353.873.603.894.134.48
–16.4329.8222.4421.0510.41199.89-19.424.14-38.28-11.11-6.787.806.318.38
45.6755.3958.4556.9555.2853.4659.7057.9250.0449.6040.5340.5340.5340.5340.53
0.520.731.001.191.401.505.013.923.532.161.571.461.571.671.81
0.050.230.280.440.400.302.561.670.810.13-0.640.040.050.050.05
4.7717.6016.6020.9115.8510.6830.4624.6211.482.90-16.661.191.181.191.21
0.030.260.330.400.390.282.091.460.800.09-0.900.020.070.070.14
–835.7126.7219.88-3.02-28.50657.25-30.10-45.11-88.53-1,080.43-102.66191.67-7.14109.23
––––0.500.200.200.350.351.000.100.100.100.10–
–––––-60.00–75.00–185.71-90.00––––
244.60338.60360.00379.10400.10400.10399.30411.68410.37412.34412.38412.38412.38412.38412.38
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales BGI Genomics Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue BGI Genomics Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare BGI Genomics Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares BGI Genomics Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against BGI Genomics Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

BGI Genomics Co stock margins

The BGI Genomics Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BGI Genomics Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BGI Genomics Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
59.71 %
30.47 %
24.89 %
Jan 1, 2021
57.93 %
24.63 %
21.60 %
Jan 1, 2022
50.05 %
11.49 %
11.40 %
Jan 1, 2023
49.60 %
2.92 %
2.14 %
Jan 1, 2024
40.54 %
-16.67 %
-23.34 %
Jan 1, 2025 (e)
40.54 %
1.21 %
0.69 %
Jan 1, 2026 (e)
40.54 %
1.21 %
1.80 %
Jan 1, 2027 (e)
40.54 %
1.21 %
1.60 %

BGI Genomics Co Stock Revenue, EBIT, Earnings per Share

The BGI Genomics Co earnings per share therefore indicates how much revenue BGI Genomics Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
21.03 CNY
6.41 CNY
5.23 CNY
Jan 1, 2021
16.44 CNY
4.05 CNY
3.55 CNY
Jan 1, 2022
17.17 CNY
1.97 CNY
1.96 CNY
Jan 1, 2023
10.55 CNY
0.31 CNY
0.23 CNY
Jan 1, 2024
9.38 CNY
-1.56 CNY
-2.19 CNY
Jan 1, 2025 (e)
8.74 CNY
0.11 CNY
0.06 CNY
Jan 1, 2026 (e)
9.42 CNY
0.11 CNY
0.17 CNY
Jan 1, 2027 (e)
10.02 CNY
0.12 CNY
0.16 CNY

BGI Genomics Co business model & stock analysis

BGI Genomics Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

BGI Genomics Co historical P/E ratio, EBIT multiple, and P/S ratio

BGI Genomics Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

BGI Genomics Co shares outstanding

The number of shares of BGI Genomics Co was 412.38 M in 2025. This indicates how many shares BGI Genomics Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
399.30 M Stocks
Jan 1, 2021
411.68 M Stocks
Jan 1, 2022
410.37 M Stocks
Jan 1, 2023
412.34 M Stocks
Jan 1, 2024
412.38 M Stocks
Jan 1, 2025 (e)
412.38 M Stocks
Jan 1, 2026 (e)
412.38 M Stocks
Jan 1, 2027 (e)
412.38 M Stocks

BGI Genomics Co Dividend History

7 years of dividend payments

YearAnnual DividendYoY ChangePayments
20240.10CNY↓ 90.0%1×
20231.00CNY↑ 185.7%1×
20220.35CNY 0.0%1×
20210.35CNY↑ 246.5%1×
20200.10CNY↑ 1.0%1×
20190.10CNY↓ 80.0%1×
20180.50CNY—2×

BGI Genomics Co dividend history and estimates

In 2025, BGI Genomics Co paid a dividend amounting to 0.10 CNY. Dividend means that BGI Genomics Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020 (e)
0.10 CNY
0.10 CNY
Jan 1, 2021
0.35 CNY
0.00 CNY
Jan 1, 2022
0.35 CNY
0.00 CNY
Jan 1, 2023
1.00 CNY
0.00 CNY
Jan 1, 2024
0.10 CNY
0.00 CNY
Jan 1, 2025 (e)
0.00 CNY
0.10 CNY
Jan 1, 2026 (e)
0.00 CNY
0.10 CNY
Jan 1, 2027 (e)
0.00 CNY
0.10 CNY

BGI Genomics Co dividend payout ratio

In 2025, BGI Genomics Co had a payout ratio of 166.67%. The payout ratio indicates the percentage of the company's profits that BGI Genomics Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
1.93 %
Jan 1, 2021
9.86 %
Jan 1, 2022
17.89 %
Jan 1, 2023
443.85 %
Jan 1, 2024
-4.57 %
Jan 1, 2025 (e)
166.67 %
Jan 1, 2026 (e)
58.82 %
Jan 1, 2027 (e)
62.50 %

Current BGI Genomics Co forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
80.00 % (4)
Hold
20.00 % (1)
Sell
0.00 % (0)
12M Price Target
58.87
Last Price
40.00
Currency
CNY
12M Return Potential
47.19 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the BGI Genomics Co stock

63/100
58
Environment
99
Social
32
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees56.726
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

BGI Genomics Co shareholder structure

% Name
0.20082%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.05040%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.04023%
Handelsbanken Kapitalförvaltning AB
Handelsbanken Kapitalförvaltning AB
0.03007%
Mirae Asset Global Investments (Hong Kong) Limited
Mirae Asset Global Investments (Hong Kong) Limited
0.01459%
Mirae Asset Global Investments Co., Ltd.
Mirae Asset Global Investments Co., Ltd.
0.01018%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.

BGI Genomics Co Beneficial Ownership Filings (SEC 13D/G)

Free Float
56.9%
Float Shares
-
Shares Outstanding
-

BGI Genomics Co Executives and Management Board

12 members · avg. age 49 · 25 % women

YW

Mr. Yujue Wang (47)

Chief Financial Officer, Deputy General Manager, Director · since 2021

1.31 M CNY

Management

HL

Mr. Hao Li (43)

Deputy General Manager

496,500.00 CNY
YY

Ms. Yun Yang (46)

Deputy General Manager

495,900.00 CNY

Board of Directors

LZ

Mr. Lijian Zhao (49)

General Manager, Director · since 2021

2.14 M CNY
SZ

Mr. Shida Zhu (38)

Deputy General Manager, Director · since 2021

1.50 M CNY
NL

Mr. Ning Li (44)

Deputy General Manager, Director · since 2021

1.41 M CNY
QX

Ms. Qian Xu (41)

General Counsel, Deputy General Manager, Secretary of the Board

1.36 M CNY
GZ

Mr. Guocheng Zhang (59)

Director

541,300.00 CNY
LD

Ms. Lan Du (49)

Independent Director

252,000.00 CNY

BGI Genomics Co Supply Chain

BGI Genomics Co Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
6 companies
#NameTrend
1
Dawning Information Ind A
Supplier·Technology Hardware, Storage & Peripherals·CN
-0.25
0.08
0.88
0.55
0.20
0.73
2
Champions Oncology
Supplier·Life Sciences Tools & Services·US
-0.38
-0.80
0.79
0.58
0.58
0.43
#NameTrend
1
Ronglian Group A
Supplier·IT Services·CN
-0.21
0.47
0.87
0.36
-0.31
—
2
II-VI
Supplier·Electronic Equipment, Instruments & Components·US
-0.35
-0.25
0.72
0.46
0.32
-0.17
3
Beihai Gofar Chuanshan A
Supplier·Customer·Chemicals·CN
-0.05
-0.27
-0.53
0.27
0.20
0.05
4
Natera
Supplier·Customer·Biotechnology·US
-0.09
-0.21
0.52
0.70
0.70
0.13

Frequently asked questions about BGI Genomics Co

Analysts currently set an average price target of 58.87 CNY for the BGI Genomics Co stock (median: 58.87 CNY), implying +47.2 % versus the latest price. The consensus is based on 5 analyst ratings.

BGI Genomics Co Analyst Price Targets 2026

5 analysts currently rate the BGI Genomics Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BGI Genomics Co to generate revenue of 3.89 B CNY and earnings per share of 0.17 CNY.

BGI Genomics Co Analyst Price Targets 2026

Converted at the current exchange rate, the BGI Genomics Co share trades at 5.13 EUR (40.00 CNY).

No history available for BGI Genomics Co.

The expected revenue of BGI Genomics Co is 3.89 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of BGI Genomics Co is 70.10 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of BGI Genomics Co is currently 235.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BGI Genomics Co stock.

The price-to-sales ratio (P/S) of BGI Genomics Co is currently 4.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BGI Genomics Co stock.

The Eulerpool Quality Score for BGI Genomics Co is 1/10.

The ISIN of BGI Genomics Co is CNE100003449. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of BGI Genomics Co is 300676.SZ. The ticker symbol is used to trade BGI Genomics Co shares on the stock exchange.

Over the past 12 months, BGI Genomics Co paid a dividend of 0.10 CNY . This corresponds to a dividend yield of about 0.25 %. For the coming 12 months, BGI Genomics Co is expected to pay a dividend of 0.10 CNY.

The current dividend yield of BGI Genomics Co is 0.25 %.

BGI Genomics Co pays a dividend, distributed in the months of , , , .

BGI Genomics Co paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.10 CNY are expected. This corresponds to a dividend yield of 0.25 %.

BGI Genomics Co is assigned to the 'Health' sector.

To receive the latest dividend of BGI Genomics Co from amounting to 0.1 CNY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, BGI Genomics Co distributed 0.1 CNY as dividends.

The dividends of BGI Genomics Co are distributed in CNY.

All fundamentals and in-depth analysis of BGI Genomics Co

Our stock analysis for BGI Genomics Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BGI Genomics Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

BGI Genomics Co Stock
BGI Genomics Co Revenue→
BGI Genomics Co Stock
BGI Genomics Co Net Income→
BGI Genomics Co Stock
BGI Genomics Co P/E→
BGI Genomics Co Stock
BGI Genomics Co P/S→
BGI Genomics Co Stock
BGI Genomics Co EBIT→
BGI Genomics Co Stock
BGI Genomics Co Dividend→
BGI Genomics Co Stock
BGI Genomics Co Directors Dealings→
BGI Genomics Co Stock
BGI Genomics Co Stocks→
BGI Genomics Co Stock
BGI Genomics Co Market capitalization→
BGI Genomics Co Stock
BGI Genomics Co Debt→
BGI Genomics Co Stock
BGI Genomics Co Liabilities→
BGI Genomics Co Stock
BGI Genomics Co Equity→
BGI Genomics Co Stock
BGI Genomics Co AAQS→
BGI Genomics Co Stock
BGI Genomics Co Employees→
BGI Genomics Co Stock
BGI Genomics Co ROE→
BGI Genomics Co Stock
BGI Genomics Co ROA→
BGI Genomics Co Stock
BGI Genomics Co ROCE→
BGI Genomics Co Stock
BGI Genomics Co News→
BGI Genomics Co Stock
BGI Genomics Co Analyst Price Targets→

Health Stocks

BGM GroupBG MedicineBharat Immunologicals and Biologicals CorporationBeyondspringBharat ParenteralsBeyond AirBibbInstrumentsBetterLife PharmaBicara TherapeuticsBetter TherapeuticsBICO GroupBetta Pharmaceuticals CoAll Stocks A–Z →